We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Strategic Development Partnership between Farfield Scientific and Monash University
News

Strategic Development Partnership between Farfield Scientific and Monash University

Strategic Development Partnership between Farfield Scientific and Monash University
News

Strategic Development Partnership between Farfield Scientific and Monash University

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Strategic Development Partnership between Farfield Scientific and Monash University"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Farfield Scientific Limited and the Department of Biochemistry and Molecular Biology at Monash University have recently entered a strategic partnership to create a series of biosensor surfaces that will be used to establish a new approach to the structural analysis of membrane protein function.

The partnership has recently attracted Australian Research Council funding at Monash. The aim of the collaboration is to commercialise a new generation of membrane-mimetic biosensor surfaces which can be used to analyse the structure and function of membrane-associating peptides and proteins.

Dr Gerry Ronan, CEO at Farfield Scientific said, "Dr Aguilar’s research into membrane proteins is internationally renowned and we are delighted that she has chosen to undertake this work with her AnaLight® facility. Membrane proteins are the subject of intense academic and commercial interest as they are the gateways to the cell but they are notoriously difficult to study."

Dr. Ronan continued, "This collaboration will deliver a bioanalytical toolkit which will transform the life scientist’s ability to unravel the mechanisms by which these proteins function and will ultimately lead to an entirely new approach to structurally informed drug discovery."

Advertisement